Development Partner for Cell and Gene Therapies

Accelerate your cell or gene therapies to market with tailored clinical and regulatory strategies and expert insights.

We understand how high the stakes are with your advanced cell or gene therapy program. In this specialized area, study design, conduct, and regulatory processes are not standard. Veristat has successfully supported over 115 cell and gene therapy clinical trials and consulting projects in the past 5 years, with a global team of scientific experts adept at both strategy and execution across the clinical development journey.

Whatever the study’s unique considerations – patients, products, process, follow-up, regulatory – Veristat can successfully get you through it.  Let's Talk. 

Advanced Therapies Require Special Regulatory Focus

Maintaining strong relationships and interactions with key global regulatory agencies is critical. Our team has deep expertise in all accelerated pathways to approval, and in applying for and retaining special designations. In the past 5 years,  Veristat has completed more than 85  cell and gene therapy clinical trial applications and marketing applications.    Through ongoing regulatory engagement, we keep up with the constantly changing landscape for advanced cell and gene therapy products.


cell and gene therapy clinical trials and consulting projects


INDs and CTAs prepared


Marketing Applications Prepared

Experience Across Product Types

No matter your product, we can assist you in bringing it to the patients that need it. Veristat has extensive global expertise supporting gene therapies, cell therapies, and tissue engineering, including the first gene therapy approved in the western world.

Advancing Revolutionary Therapies Podcast: Cell & Gene

In cell and gene therapy development, nothing is standard. Whether you are just starting out— or have deep expertise, there is always something new to learn. Listen to ART: Advancing Revolutionary Therapies, a podcast series. Hear Veristat thought leaders draw on their specialized expertise to provide key takeaways to help steer your cell and gene therapy program in the right direction.


"The challenges of developing cell and gene therapies requires a committed and experienced partner. Cell and gene therapies offer uniquely curative potential for disorders that are intractable to other treatment modalities. They can save lives. The challenge now is to scale the opportunity they offer to their full potential."
Patrick Flanagan
Chief Executive Officer, Veristat

Life-changing Work with Unique Challenges

Each cell and gene therapy is different, with a complicated regulatory approval process that is full of unknowns.

  • Do not follow a classic route to market
  • Demand more complex clinical program planning 
  • Can depend upon the right regulatory pathway 
  • Often use non-randomized or natural history trial design 
  • Require long-term follow-up rollover studies 


Learn More with These Resources

Case Study

Advancing to Your Next Milestone – Global Regulatory ...

Fact Sheet

Veristat Corporate Fact Sheet

Fact Sheet

Rare Disease Fact Sheet